Evaldo Marchi

Prof. Dr. Evaldo Marchi

orcid

Research Focus & Metrics

Academic Career Length

30Years (1997-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2005 in Chest
Verified
Journal Article
Closed access
PDF file
MPMarcello da Silveira Paschoalini
Marcello da Silveira Paschoalini
FVFrancisco S. Vargas
Francisco S. Vargas
EMEvaldo Marchi
Evaldo Marchi
JPJosé Rodrigues Pereira
José Rodrigues Pereira
FJFabio B. Jatene
Fabio B. Jatene
RLRichard W. Light
Richard W. Light

1 June 2011 in Chest
Verified
Journal Article
Closed access
PDF file
ACAna Maria Cartaxo
Ana Maria Cartaxo
FVFrancisco S. Vargas
Francisco S. Vargas
JSJoão Marcos Salge
João Marcos Salge
BMBianca F. Marcondes
Bianca F. Marcondes
EGEduardo H. Genofre
Eduardo H. Genofre
LTLisete R. Teixeira
Lisete R. Teixeira

29 December 2018 in Journal of Orthopaedic Surgery and Research
Verified
Journal Article
Open access
PDF file
MCMartha Cecilia Castano-Betancourt
Martha Cecilia Castano-Betancourt
RARicardo Annichino
Ricardo Annichino
MMMarcelo de Azevedo e Souza Munhoz
Marcelo de Azevedo e Souza Munhoz
EMEduardo Gomes Machado
Eduardo Gomes Machado
MLMonica Vannucci Lipay
Monica Vannucci Lipay
EMEvaldo Marchi
Evaldo Marchi
Total joint arthroplasty (TJA) benefit patients with osteoarthritis (OA) and rheumatoid arthritis (RA). However, a specific approach to detect patients at higher risk of prosthetic joint infection (PJI) and mechanical complications is absent. The aim of this study is to identify groups at higher risk for infections and mechanical complications after TJA in patients with RA and OA based on their most significant predictors. This is a hospital-based cohort study with 1150 recipients of TJA. Risk factors and comorbidities were assessed prior to the index surgery. Multivariate logistic and hazard regression were used to determine the relationship between risk factors and occurrence of complications after TJA. Odds ratios (OR), hazard ratios (HR), 95% confidence intervals (CI), and comparison between areas under the curve (AUC) using DeLong’s method are presented. Complications were more frequent in subjects with RA, use of corticosteroids, and previous comorbidities: respiratory disease, infections, diabetes, anemia, mental and musculoskeletal comorbidities than in subjects without these risk factors, and these factors were predictors of infections and mechanical complications (P < 0.05). A model including these factors was superior to a model with only type of joint disease (OA/RA) or age and gender to detect infections or mechanical complications after TJA (P < 0.05 for difference between models). Complication risk proportionally increased with the presence of two or more comorbidities (P < 0.001). There are two groups at higher risk for infections after TJA: patients with OA with at least two risk factors and patients with RA, who usually present at least one of the risk factors for infection.

1 June 2004 in Chest
Verified
Journal Article
Closed access
EMEvaldo Marchi
Evaldo Marchi
FVFrancisco S. Vargas
Francisco S. Vargas
MAMilena M.P. Acencio
Milena M.P. Acencio
LALeila Antonangelo
Leila Antonangelo
LTLisete R. Teixeira
Lisete R. Teixeira
RLRichard W. Light
Richard W. Light

1 December 2005 in Chest
Verified
Journal Article
Closed access
PDF file
LTLisete R. Teixeira
Lisete R. Teixeira
FVFrancisco S. Vargas
Francisco S. Vargas
MAMilena M. P. Acencio
Milena M. P. Acencio
PPPedro F. S. Paz
Pedro F. S. Paz
LALeila Antonangelo
Leila Antonangelo
EMEvaldo Marchi
Evaldo Marchi

1 September 2000 in Chest
Verified
Journal Article
Closed access
FVFrancisco S. Vargas
Francisco S. Vargas
LTLisete R. Teixeira
Lisete R. Teixeira
MVMarcelo A.C. Vaz
Marcelo A.C. Vaz
ACAlipio O. Carmo
Alipio O. Carmo
EMEvaldo Marchi
Evaldo Marchi
RLRichard W. Light
Richard W. Light